CBD for Menstrual Pain: Does It Actually Work?
CBD for Menstrual Pain: Does It Actually Work?
A clear UK 2026 educational guide to CBD and menstrual pain research. Important: severe menstrual pain may indicate underlying conditions (endometriosis + adenomyosis + fibroids) requiring medical assessment; CBD edibles are food supplements not medicines and cannot diagnose + treat + cure + prevent menstrual pain or any condition; preliminary research is limited and not conclusive; if struggling please speak to your GP, NHS 111, or contact Endometriosis UK 0808 808 2227. UK Novel Food regulated + UK 18+ verification + within FSA 70mg/day recommendation. UK FSA compliant.
The verdict
Important UK 2026Severe menstrual pain may need medical care, CBD not a treatment.
GP + Endometriosis UK + NHS first. Educational only.
0808 8082227
Endometriosis UK
NHS111
Menstrual support
Important UK 2026 + severe menstrual pain may indicate underlying conditions (endometriosis + adenomyosis + fibroids + pelvic inflammatory disease) requiring medical assessment + CBD edibles are food supplements not medicines + cannot diagnose + treat + cure + prevent menstrual pain or any condition; preliminary research on CBD and menstrual pain is very limited and not conclusive; if struggling please speak to your GP + NHS 111 + or contact Endometriosis UK 0808 808 2227; drug interactions critical with hormonal contraception + pain medications; UK Novel Food regulated + 1mg THC max + UK 18+ verification + within FSA 70mg/day recommendation. Menstrual pain (dysmenorrhoea) overview: primary dysmenorrhoea (no underlying cause) + secondary dysmenorrhoea (underlying cause like endometriosis + adenomyosis + fibroids); sustained UK NHS framework. Affects significant proportion of UK women: significant public health condition + sustained UK NHS framework + NHS statistics. NHS provides comprehensive menstrual pain care: GP-led + gynaecologist referral if needed + sustained UK NHS framework. NHS support resources priority: NHS 111: non-emergency menstrual support + sustained UK NHS framework. NHS 999: emergency severe pelvic pain + heavy bleeding + sustained UK NHS framework. GP appointment: menstrual pain assessment + treatment + gynaecology referral if needed + sustained UK NHS framework. Endometriosis UK 0808 808 2227: helpline + sustained UK consumer protection. Wellbeing of Women: women's health support + sustained UK consumer protection. Adenomyosis Advice Association: sustained UK consumer protection. Don't use CBD as substitute for menstrual pain treatment: requires evidence-based treatment + GP-managed + sustained UK NHS framework. Drug interactions critical with hormonal contraception + pain medications: CBD interacts with CYP3A4 + CYP2C19 enzymes; hormonal contraception (combined pill + progesterone-only pill + others) + NSAIDs + many others affected; CBD theoretically may reduce hormonal contraception effectiveness + always consult GP + sustained UK consumer protection. Preliminary research limitations: scientific research very limited + not conclusive + sustained UK consumer awareness; CBD products are not approved medical treatments in UK. CBD is a food supplement not a medicine. UK FSA compliant.
NHS support resources priority
0808 8082227
Endometriosis UK
Helpline + information + support. Sustained UK consumer protection.
NHS111
Menstrual support
Non-emergency menstrual support. Sustained UK NHS framework.
GP
Gynaecology referral
Menstrual pain assessment + specialist care. NHS framework.
CBD and menstrual pain research: UK 2026 educational overview
Important context: severe menstrual pain needs assessment
Important context for CBD and menstrual pain discussion + sustained UK NHS framework + sustained UK consumer protection + UK FSA Novel Food framework. Menstrual pain (dysmenorrhoea) types: Primary dysmenorrhoea: pain without underlying gynaecological cause + typically starts at puberty + caused by uterine prostaglandins; sustained UK NHS framework. Secondary dysmenorrhoea: pain caused by underlying gynaecological condition + endometriosis + adenomyosis + fibroids + pelvic inflammatory disease (PID) + ovarian cysts + others; sustained UK NHS framework + sustained UK consumer awareness. Severe menstrual pain may indicate underlying conditions: endometriosis (tissue similar to womb lining grows outside womb + significant cause of pelvic pain) + adenomyosis + fibroids + PID + others; require medical assessment + sustained UK NHS framework + sustained UK consumer protection. Endometriosis affects approximately 1 in 10 UK women: significant public health condition + average diagnostic delay 7-8 years + sustained UK NHS framework + Endometriosis UK statistics. NHS 999 emergency symptoms: severe sudden pelvic pain + heavy bleeding (soaking pad/tampon every hour or more) + signs of shock + suspected ectopic pregnancy + sustained UK NHS framework + sustained UK consumer protection. NHS provides comprehensive menstrual pain care: GP-led assessment + gynaecologist referral if needed + sustained UK NHS framework. NHS support resources priority over CBD considerations: NHS 999: emergency symptoms above + sustained UK NHS framework. NHS 111: non-emergency menstrual support + sustained UK NHS framework. GP appointment: menstrual pain assessment + treatment + gynaecology referral if needed + sustained UK NHS framework. Gynaecologist consultation: GP referral + sustained UK NHS framework + sustained UK consumer protection. Endometriosis UK 0808 808 2227: helpline + information + support + sustained UK consumer protection. Wellbeing of Women: women's health support + sustained UK consumer protection. Adenomyosis Advice Association: sustained UK consumer protection. Fibroid charities: sustained UK consumer protection. Mental health support: chronic menstrual pain + mental health closely linked + Samaritans 116 123 + Mind UK 0300 123 3393 + sustained UK consumer protection. Don't use CBD as substitute for menstrual pain treatment: requires evidence-based treatment + GP-managed + sustained UK NHS framework + sustained UK consumer protection. CBD edibles are food supplements not medicines: cannot diagnose + treat + cure + prevent menstrual pain or any condition + sustained UK FSA Novel Food framework + UK Trading Standards quality. CBD products are not approved medical treatments in UK: regardless of marketing claims + sustained UK consumer protection. UK Trading Standards investigations: misleading medical claims + non-compliant products + sustained UK consumer protection. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot make medical claims + provide product information + lab testing certificates + UK 18+ age verification + refer customers to GP + sustained UK consumer protection. Drug interactions critical with hormonal contraception + pain medications: CBD interacts with CYP3A4 + CYP2C19 enzymes; hormonal contraception + NSAIDs + many others affected; CBD theoretically may reduce hormonal contraception effectiveness + always consult GP + sustained UK consumer protection. UK Novel Food regulated: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality. UK FSA compliant. CBD is a food supplement not a medicine.
NHS menstrual pain treatment evidence-based
NHS menstrual pain treatment evidence-based + sustained UK NHS framework + sustained UK consumer protection + UK FSA Novel Food framework. NHS menstrual pain treatment evidence-based: GP-led + gynaecologist referral if needed + sustained UK NHS framework. Primary dysmenorrhoea treatment: NSAIDs first-line: ibuprofen + naproxen + mefenamic acid; reduce prostaglandins + sustained UK NHS framework. Paracetamol: alternative or addition + sustained UK NHS framework. Hormonal contraception: combined oral contraceptive pill + progesterone-only methods + Mirena (LNG-IUS) + sustained UK NHS framework + suppress ovulation + reduce menstrual pain. Lifestyle measures: heat (hot water bottle) + regular exercise + healthy diet + adequate sleep + reduced stress + sustained UK NHS framework. TENS machine: transcutaneous electrical nerve stimulation + sustained UK NHS framework. Secondary dysmenorrhoea treatment: Endometriosis: NICE guidelines (NG73) + GP + gynaecologist + hormonal treatments (combined pill + progestogens + GnRH analogues) + surgical treatment (laparoscopy) + sustained UK NHS framework. Adenomyosis: hormonal treatments + surgical options + sustained UK NHS framework. Fibroids: NICE guidelines (NG88) + medical + surgical options + sustained UK NHS framework. PID: antibiotics + sustained UK NHS framework. Specialist services: gynaecologist + endometriosis specialist centre + pain clinic + sustained UK NHS framework. Crisis support priority: NHS 999: emergency severe pelvic pain + heavy bleeding + sustained UK NHS framework. NHS 111: non-emergency menstrual support + sustained UK NHS framework. Endometriosis UK 0808 808 2227: helpline + sustained UK consumer protection. Don't replace prescribed menstrual pain medications with CBD: CBD is food supplement not medicine + cannot replace prescribed treatment + can affect medication blood levels via CYP450 enzymes + always consult GP + sustained UK consumer protection. Drug interactions critical with hormonal contraception + pain medications: CBD interacts with CYP3A4 + CYP2C19 enzymes; hormonal contraception (CBD theoretically may reduce effectiveness particularly progestogen-only methods + careful consideration with GP + alternative or additional contraception may be needed) + NSAIDs + many others affected; always consult GP + sustained UK consumer protection. Lifestyle support alongside NHS treatment: heat + regular exercise + healthy diet + adequate sleep + stress management + sustained UK NHS framework + sustained UK consumer wellbeing. UK NHS framework comprehensive: GP + gynaecologist + endometriosis specialist + sustained UK NHS framework. CBD is a food supplement not a medicine: cannot diagnose + treat + cure + prevent menstrual pain + sustained UK FSA Novel Food framework + UK Trading Standards quality. CBD products are not approved medical treatments in UK: sustained UK consumer protection. UK Novel Food regulated: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot make medical claims + sustained UK consumer protection. UK FSA compliant.
Preliminary CBD + menstrual pain research very limited
Preliminary CBD + menstrual pain research very limited + sustained UK consumer awareness + UK FSA Novel Food framework educational overview only. Scientific research on CBD + menstrual pain ongoing very limited: preliminary studies exploring CBD interactions with endocannabinoid system + theoretical pain modulation + theoretical anti-inflammatory pathways + sustained scientific research interest; not conclusive evidence; CBD products are not approved medical treatments in UK. Methodological limitations: very small studies + variable CBD products + variable doses + heterogeneous populations + short duration + lack of large randomised controlled trials specific to menstrual pain + sustained UK consumer awareness; insufficient for clinical recommendations. Theoretical mechanisms: CBD acts as indirect modulator of endocannabinoid system + may interact with TRPV1 receptors + theoretical anti-inflammatory pathways + sustained scientific research interest; not conclusive. Animal vs human studies: very limited human research on CBD specifically for menstrual pain + sustained UK consumer awareness. Endometriosis research: some preliminary CBD research on endometriosis + theoretical mechanisms; not conclusive + sustained UK consumer awareness. Don't make medical claims based on preliminary research: scientific research is preliminary very limited + not conclusive + CBD edibles cannot diagnose + treat + cure + prevent menstrual pain or any condition + sustained UK FSA Novel Food framework + UK Trading Standards quality. UK FSA precautionary approach: 70mg/day recommendation precautionary + long-term effects above this level not yet fully understood + sustained UK consumer protection. UK regulatory framework: CBD products not approved medical treatments in UK + UK Novel Food regulated since 31 March 2021 + sustained UK Trading Standards quality + sustained UK consumer protection. UK Trading Standards investigations: misleading medical claims + non-compliant products + sustained UK consumer protection. NICE evidence-based guidelines: don't recommend CBD for menstrual pain or endometriosis + recommend evidence-based treatments + sustained UK NHS framework. Don't use CBD as substitute for evidence-based menstrual pain treatment: requires GP consultation + sustained UK NHS framework + sustained UK consumer protection. NHS support resources priority over CBD considerations: GP + NHS 111 + Endometriosis UK 0808 808 2227 + Wellbeing of Women + Adenomyosis Advice Association + gynaecologist + sustained UK consumer protection. Drug interactions critical with hormonal contraception + pain medications: CBD interacts with CYP3A4 + CYP2C19 enzymes; hormonal contraception + NSAIDs + many others affected; CBD theoretically may reduce hormonal contraception effectiveness + always consult GP + sustained UK consumer protection. Pregnancy + breastfeeding: FSA precautionary advice; if planning pregnancy or pregnant + always consult GP before CBD + sustained UK consumer protection. Underlying health conditions: GP consultation essential. UK 18+ verification: established UK retailers verify age + never sold to under-18s + sustained UK consumer protection. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot make medical claims + provide product information + sustained UK consumer protection. UK Novel Food regulated: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality. UK FSA compliant. CBD is a food supplement not a medicine.
Drug interactions with hormonal contraception + pain medications critical
Drug interactions between CBD and hormonal contraception + pain medications critical safety concern + sustained UK consumer protection + UK FSA Novel Food framework. CYP450 enzyme interactions: CBD inhibits CYP3A4 + CYP2C19 liver enzymes that metabolise many hormonal contraceptives + pain medications + can affect blood levels + sustained UK consumer protection. Hormonal contraception critical: Combined oral contraceptive pill: ethinylestradiol + progestogens; CBD may theoretically affect blood levels + theoretical reduced effectiveness + always consult GP + sustained UK consumer protection. Progesterone-only pill (POP): levonorgestrel + desogestrel + drospirenone + others; CBD theoretically may reduce effectiveness particularly low-dose POPs + always consult GP + sustained UK consumer protection. Hormonal patches + rings: similar concerns + always consult GP + sustained UK consumer protection. Implants + injections: long-acting hormonal contraception; sustained UK consumer awareness; always consult GP. Hormonal IUD (Mirena LNG-IUS): localised release reduces systemic interaction concerns; always consult GP + sustained UK consumer protection. Emergency contraception: levonorgestrel + ulipristal acetate; CBD may affect; always consult pharmacist + GP + sustained UK consumer protection. Alternative or additional contraception may be needed: barrier methods (condoms + diaphragm) + non-hormonal IUD (copper) + sustained UK consumer protection; always consult GP. NSAIDs commonly used for menstrual pain: ibuprofen + naproxen + mefenamic acid; CYP affected + always consult GP + sustained UK consumer protection. Paracetamol: CBD may affect liver metabolism; significant doses combined may increase liver enzyme markers + always consult GP + sustained UK consumer protection. Antidepressants used for chronic menstrual pain: SSRIs + SNRIs + tricyclic antidepressants; serotonin syndrome theoretical risk + always consult GP + sustained UK consumer protection. Hormonal endometriosis treatments: progestogens + GnRH analogues; sustained UK consumer awareness; always consult specialists. Other medications: pelvic pain medications + sustained UK consumer awareness; always consult GP. Many other medications affected: not exhaustive list + always consult GP + gynaecologist + sustained UK consumer protection. Never stop hormonal contraception or menstrual pain medications based on CBD use: dangerous + can cause unintended pregnancy + worsen pain + always consult GP + sustained UK consumer protection. Always tell GP + gynaecologist about CBD use: if taking hormonal contraception or menstrual pain medications + always consult specialists + sustained UK consumer protection. NHS pharmacist consultation: free NHS pharmacist consultation for medication queries + sustained UK NHS framework + sustained UK consumer protection. BNF (British National Formulary): prescribers reference for medication interactions + GP + pharmacist + gynaecologist resource + sustained UK NHS framework. NHS support resources priority: GP + gynaecologist + NHS 111 + NHS 999 + Endometriosis UK 0808 808 2227 + sustained UK consumer protection. Don't use CBD as substitute for menstrual pain treatment: prescribed medications evidence-based + GP-managed + sustained UK NHS framework + sustained UK consumer protection. UK Novel Food regulated: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot make medical claims + cannot provide medical advice + refer customers to GP + sustained UK consumer protection. UK Trading Standards investigations: misleading medical claims + non-compliant products + sustained UK consumer protection. Pregnancy + breastfeeding: FSA precautionary advice + sustained UK consumer protection. Underlying health conditions: GP consultation essential. UK 18+ verification: established UK retailers verify age + never sold to under-18s + sustained UK consumer protection. UK consumer rights: faulty products = retailer replacement obligation under Consumer Rights Act 2015. UK FSA compliant. CBD is a food supplement not a medicine + cannot diagnose + treat + cure + prevent menstrual pain or any condition.
When to seek help + menstrual support
When to seek help + menstrual support priority over CBD considerations + sustained UK NHS framework + sustained UK consumer protection. Seek help if menstrual pain symptoms: severe pain + pain interfering with daily activities + work + school + sleep + relationships + new pain pattern + worsening pain + pain not responding to NSAIDs + heavy bleeding + sustained UK NHS framework. Possible signs of underlying condition: severe pelvic pain + chronic pelvic pain + pain during sex + painful bowel movements + heavy bleeding + irregular periods + difficulty conceiving + sustained UK NHS framework + may indicate endometriosis + adenomyosis + fibroids + others. NHS 999 emergency symptoms: severe sudden pelvic pain + heavy bleeding (soaking pad/tampon every hour or more) + signs of shock + suspected ectopic pregnancy + sustained UK NHS framework + sustained UK consumer protection. NHS 111: non-emergency menstrual support + sustained UK NHS framework. GP appointment: menstrual pain assessment + treatment + gynaecology referral if needed + sustained UK NHS framework. Gynaecologist consultation: GP referral + sustained UK NHS framework + sustained UK consumer protection. Endometriosis specialist centres: severe + complex cases + sustained UK NHS framework. Endometriosis UK 0808 808 2227: helpline + information + support + sustained UK consumer protection. Wellbeing of Women: women's health + sustained UK consumer protection. Adenomyosis Advice Association: sustained UK consumer protection. Fibroid charities: sustained UK consumer protection. Mental health support: chronic menstrual pain + mental health closely linked + Samaritans 116 123 + Mind UK 0300 123 3393 + NHS Talking Therapies + sustained UK consumer protection. Don't self-treat with CBD: severe menstrual pain requires evidence-based treatment + GP consultation essential + sustained UK NHS framework + sustained UK consumer protection. CBD is a food supplement not a medicine: cannot diagnose + treat + cure + prevent menstrual pain or any condition + sustained UK FSA Novel Food framework + UK Trading Standards quality. CBD products are not approved medical treatments in UK: regardless of marketing + sustained UK consumer protection. UK Trading Standards investigations: misleading medical claims + non-compliant products + sustained UK consumer protection. Drug interactions critical with hormonal contraception + pain medications: CBD interacts with CYP3A4 + CYP2C19 enzymes; hormonal contraception (CBD theoretically may reduce effectiveness) + NSAIDs + many others affected; never stop hormonal contraception or menstrual pain medications based on CBD use + always consult GP + sustained UK consumer protection. UK Novel Food regulated: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality + UK 18+ verification. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot make medical claims + provide product information + lab testing certificates + sustained UK consumer protection. Pregnancy + breastfeeding: FSA precautionary advice + sustained UK consumer protection. UK consumer rights: faulty products = retailer replacement obligation under Consumer Rights Act 2015. UK FSA compliant. CBD is a food supplement not a medicine + cannot diagnose + treat + cure + prevent any condition.
Six priority NHS steps
GP appointment
Menstrual pain assessment + gynaecology referral if needed. NHS framework.
NHS 999 if severe
Severe sudden pelvic pain + heavy bleeding. Sustained UK NHS framework.
NHS 111 non-emergency
Menstrual support. Sustained UK NHS framework.
Endometriosis UK 0808 808 2227
Helpline + information + support. UK consumer protection.
Specialist endometriosis centres
Severe + complex cases. Sustained UK NHS framework.
Don't combine with hormonal contraception
CBD theoretically may reduce effectiveness. Always consult GP.
Nord 50 vs RPM 4 key points
Both UK TPD compliant
Same e-liquid compatibility + same regulatory framework + same UK 18+ verification.
NICE evidence-based guidelines
NSAIDs + hormonal contraception + treat underlying conditions. NHS framework.
CBD research very limited
Preliminary not conclusive. CBD not approved medical treatment.
Drug interactions critical
CYP3A4 + CYP2C19 affect hormonal contraception + NSAIDs.
Severe menstrual pain may indicate underlying conditions (endometriosis + adenomyosis + fibroids) requiring medical assessment. CBD edibles are food supplements not medicines and cannot diagnose + treat + cure + prevent menstrual pain. Please speak to your GP, NHS 111, or contact Endometriosis UK 0808 808 2227. UK Novel Food regulated + 1mg THC max + UK 18+ verification + within FSA 70mg/day recommendation. Always consult GP if taking hormonal contraception or pregnant or breastfeeding. CBD is a food supplement not a medicine. To pick up your CBD edibles see the CBD edibles collection.
Speak to your GP or gynaecologist
Severe menstrual pain may indicate underlying conditions (endometriosis + adenomyosis + fibroids + pelvic inflammatory disease) requiring medical assessment. CBD edibles are food supplements not medicines + cannot diagnose + treat + cure + prevent menstrual pain. Preliminary research on CBD and menstrual pain is very limited and not conclusive; if struggling please speak to your GP, NHS 111, or contact Endometriosis UK 0808 808 2227; drug interactions critical with hormonal contraception + pain medications; UK Novel Food regulated + 1mg THC max + UK 18+ verification + within FSA 70mg/day recommendation. NHS support resources priority over CBD considerations: NHS 999 emergency severe sudden pelvic pain + heavy bleeding (soaking pad/tampon every hour or more) + signs of shock + suspected ectopic pregnancy; NHS 111 non-emergency menstrual support; GP appointment menstrual pain assessment + treatment + gynaecology referral if needed; Gynaecologist consultation specialist evaluation; Endometriosis specialist centres severe + complex cases; Endometriosis UK 0808 808 2227 helpline + information + support; Wellbeing of Women women's health support; Adenomyosis Advice Association; Fibroid charities; mental health support Samaritans 116 123 + Mind UK 0300 123 3393 + NHS Talking Therapies (chronic menstrual pain + mental health closely linked). Important context: menstrual pain (dysmenorrhoea) types primary dysmenorrhoea (no underlying cause + typically starts at puberty + caused by uterine prostaglandins) and secondary dysmenorrhoea (caused by underlying gynaecological condition); severe menstrual pain may indicate endometriosis (tissue similar to womb lining grows outside womb + significant cause of pelvic pain affects approximately 1 in 10 UK women + average diagnostic delay 7-8 years) + adenomyosis + fibroids + pelvic inflammatory disease (PID) + ovarian cysts. NHS menstrual pain treatment evidence-based: GP-led + gynaecologist referral if needed; primary dysmenorrhoea treatment NSAIDs first-line (ibuprofen + naproxen + mefenamic acid reduce prostaglandins) + paracetamol + hormonal contraception (combined oral contraceptive pill + progesterone-only methods + Mirena LNG-IUS suppress ovulation + reduce menstrual pain) + lifestyle measures (heat hot water bottle + regular exercise + healthy diet + adequate sleep + reduced stress) + TENS machine; secondary dysmenorrhoea treatment endometriosis (NICE NG73 + GP + gynaecologist + hormonal treatments combined pill + progestogens + GnRH analogues + surgical treatment laparoscopy) + adenomyosis (hormonal + surgical) + fibroids (NICE NG88 + medical + surgical) + PID (antibiotics) + specialist services (gynaecologist + endometriosis specialist centre + pain clinic). Preliminary CBD + menstrual pain research very limited: scientific research preliminary very limited not conclusive; methodological limitations very small studies + variable CBD products + variable doses + heterogeneous populations + short duration + lack of large randomised controlled trials specific to menstrual pain; theoretical mechanisms (endocannabinoid system + TRPV1 + theoretical anti-inflammatory); animal vs human evidence very limited; endometriosis preliminary research not conclusive; CBD products are not approved medical treatments in UK. Don't make medical claims about CBD and menstrual pain: CBD edibles cannot diagnose + treat + cure + prevent menstrual pain or any condition. Drug interactions critical with hormonal contraception + pain medications: CBD inhibits CYP3A4 + CYP2C19 liver enzymes; hormonal contraception critical (combined oral contraceptive pill ethinylestradiol + progestogens CBD may theoretically affect blood levels + theoretical reduced effectiveness; progesterone-only pill levonorgestrel + desogestrel + drospirenone CBD theoretically may reduce effectiveness particularly low-dose POPs; hormonal patches + rings similar concerns; implants + injections; hormonal IUD Mirena LNG-IUS localised release reduces systemic interaction concerns; emergency contraception levonorgestrel + ulipristal acetate); alternative or additional contraception may be needed (barrier methods condoms + diaphragm + non-hormonal IUD copper); NSAIDs commonly used for menstrual pain (ibuprofen + naproxen + mefenamic acid); paracetamol may affect liver metabolism; antidepressants used for chronic menstrual pain (SSRIs + SNRIs + tricyclic antidepressants serotonin syndrome theoretical risk); hormonal endometriosis treatments (progestogens + GnRH analogues); never stop hormonal contraception or menstrual pain medications based on CBD use (dangerous + can cause unintended pregnancy + worsen pain + always consult GP). Don't use CBD as substitute for menstrual pain treatment: prescribed medications evidence-based + GP-managed. When to seek help: severe pain + interference with daily activities + new pain pattern + worsening pain + pain not responding to NSAIDs + heavy bleeding + chronic pelvic pain + pain during sex + painful bowel movements + difficulty conceiving (may indicate endometriosis + adenomyosis + fibroids); NHS 999 if severe sudden pelvic pain + heavy bleeding + signs of shock + suspected ectopic pregnancy. Methodical CBD use if used alongside NHS care: only after GP consultation + start low (10-25mg daily) + monitor response + adjust gradually + maintain within FSA 70mg/day recommendation + reduce if side effects + sustained UK consumer protection. Pregnancy + breastfeeding: FSA precautionary advice; if planning pregnancy or pregnant always consult GP. Underlying health conditions: GP consultation essential. Established UK retailer purchase: UK Companies House + VAT registered + UK Trading Standards monitored ensure UK Novel Food authorised products + counterfeit prevention + UK 18+ age verification + lab testing certificates + sustained UK consumer protection; cannot make medical claims; refer customers to GP for medical questions. UK consumer rights: faulty products = retailer replacement obligation under Consumer Rights Act 2015. UK FSA Novel Food regulated. UK Trading Standards compliant. UK Companies House and VAT registered. UK 18+ verification required. CBD is a food supplement not a medicine: cannot diagnose + treat + cure + prevent any condition.
More on SMOK Vape Kits
For CBD chronic pain see CBD chronic pain. For CBD anti-inflammatory see CBD anti-inflammatory. For CBD ECS see CBD endocannabinoid system.





















